Article info
PDFCurrent controversy
The deadly business of an unregulated global stem cell industry
- Correspondence to Dr Tamra Lysaght, Centre for Biomedical Ethics, Level 2 Block MD11, Clinical Research Centre, 10 Medical Drive, National University of Singapore, Singapore 117576, Singapore; tlysaght{at}nus.edu.sg
Citation
The deadly business of an unregulated global stem cell industry
Publication history
- Received November 9, 2016
- Accepted March 9, 2017
- First published March 29, 2017.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Other content recommended for you
- Current outlook of cardiac stem cell therapy towards a clinical application
- Autologous stem cell therapy in knee osteoarthritis: a systematic review of randomised controlled trials
- Autologous adipose-derived mesenchymal stem cells improve healing of coiled experimental saccular aneurysms: an angiographic and histopathological study
- Effect of autologous adipose-derived mesenchymal stem cell therapy in the treatment of an osteochondral lesion of the ankle
- Pharmacological priming of adipose-derived stem cells promotes myocardial repair
- Treatment of faecal incontinence using allogeneic-adipose-derived mesenchymal stem cells: a study protocol for a pilot randomised controlled trial
- Effect of autologous adipose-derived mesenchymal stem cell therapy in combination with autologous platelet-rich plasma in the treatment of elbow tendinopathy
- Exploiting science? A systematic analysis of complementary and alternative medicine clinic websites’ marketing of stem cell therapies
- Management of osteoarthritis - biological approaches: current concepts
- High tibial osteotomy in combination with arthroscopic abrasion arthroplasty and autologous adipose-derived mesenchymal stem cell therapy in the treatment of advanced knee osteoarthritis